The potential of Na+/Ca2+ exchange blockers in the treatment of cardiac disease

Expert Opinion on Investigational Drugs

Volumn 13, Issue 6, 2004, Pages 653-664

  Hobai, Ion A ^b   O'Rourke, Brian ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCY MEDICAL CENTER   (United States)

Author keywords

Arrythmias; Heart failure; Ischaemia; Na+ Ca2+ exchanger; Positive inotropes

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2 [4 (2,5 DIFLUOROBENZYLOXY)PHENOXY] 5 ETHOXYANILINE; 2',4' DIMETHYLBENZAMIL; 3',4' DICHLOROBENZAMIL; AMILORIDE; AMILORIDE DERIVATIVE; ANESTHETIC AGENT; ANILINE DERIVATIVE; ANTIARRHYTHMIC AGENT; ASCORBIC ACID; BEPRIDIL; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CHLORPROMAZINE; HALOTHANE; LOCAL ANESTHETIC AGENT; MEPACRINE; NEUROLEPTIC AGENT; NEW DRUG; NUCLEOTIDE; PEPTIDE; PHENYLARGINYLCYSTYLARGINYLCYSTYLPHENYLALANYLAMIDE; QUINIDINE; SODIUM CALCIUM EXCHANGE PROTEIN; TETRACAINE; UNCLASSIFIED DRUG; VERAPAMIL; 2 (2 (4 (4 NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA METHANESULFONATE; 2-(2-(4-(4-NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA METHANESULFONATE; CALCIUM; DIPHENYL ETHER DERIVATIVE; DRUG DERIVATIVE; OLIGOPEPTIDE; PHENYLALANYL ARGINYL CYSTEINYL ARGINYL SERYL PHENYLALANINAMIDE; PHENYLALANYL-ARGINYL-CYSTEINYL-ARGINYL-SERYL-PHENYLALANINAMIDE; SODIUM; THIOUREA;

CALCIUM TRANSPORT; CELL DAMAGE; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG TARGETING; GENE THERAPY; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HUMAN; INTRACELLULAR SPACE; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SODIUM CALCIUM EXCHANGE; BIOLOGICAL MODEL; CHEMISTRY; CONGESTIVE HEART FAILURE; DRUG ANTAGONISM; HEART; HEART DISEASE; HEART VENTRICLE FIBRILLATION; ION TRANSPORT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANILINE COMPOUNDS; CALCIUM; HEART; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; ION TRANSPORT; MODELS, BIOLOGICAL; OLIGOPEPTIDES; PHENYL ETHERS; SODIUM; SODIUM-CALCIUM EXCHANGER; THIOUREA; VENTRICULAR FIBRILLATION;

EID: 3042761614     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.13.6.653     Document Type: Review

References (93)

1. SIPIDO KR, VOLDERS PG, VOS MA et al.: Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc. Res. (2002) 53:782-805.
2. POGWIZD SM: Clinical potential of sodium-calcium exchanger inhibitors as antiarrhythmic agents. Drugs (2003) 63:439-452.
3. REUTER H, SEITZ N: The dependence of calcium efflux from cardiac muscle on temperature and external ion composition. J. Physiol. (1968) 195:451-470.
4. KHANANSHVILI D: Structure, mechanism and regulation of the cardiac sarcolemma Na-Ca exchanger. Adv. Mol. Cell. Biol. (1998) 23:311-358.
5. BLAUSTEIN MP, LEDERER WJ: Sodium/calcium exchange: its physiological implications. Physiol. Rev. (1999) 79:763-854.
6. EGGER M, NIGGLI E: Regulatory function of Na-Ca exchange in the heart: milestones and outlook. J. Membr. Biol. (1999) 168:107-130.
7. PHILIPSON KD, NICOLL DA: Sodium-calcium exchange: a molecular perspective. Annu. Rev. Physiol. (2000) 62:111-133.
8. 2+ exchange: molecular and pharmacological aspects. Circ. Res. (2001) 88:864-876.
9. 2+ exchanger. Science (1990) 250:562-565.
10. 2+ exchanger. Journal of Biol. Chem. (2001) 276:194-199.
11. 2+ exchanger. Proc. Natl. Acad. Sci. USA (1993) 90:3870-3874.
12. 2+-binding domain. J. Gen. Physiol. (1995) 105:403-420.
13. 2+exchange in giant excised sarcolemmal membrane patches. Nature (1990) 344:242-245.
14. 2 with the XIP region of the cardiac Na/Ca exchanger. Am. J. Physiol. Cell Physiol. (2000) 278:C661-C666.
15. PERCHENET L, HINDE AK, PATEL KC et al.: Stimulation of Na/Ca exchange by the beta-adrenergic/protein kinase A pathway in guinea-pig ventricular myocytes at 37°C. Pflugers Arch. (2000) 439:822-828.
16. 2+ exchanger via protein kinase C. J. Biol. Chem. (1996) 271:13609-13615.
17. 2+ exchanger. J. Biol. Chem. (1991) 266:1014-1020.
18. KOHOMOTO O, LEVI AJ, BRIDGE JH: Relation between reverse sodium-calcium exchange and sarcoplasmic reticulum calcium release in guinea pig ventricular cells. Circ. Res. (1994) 74:550-554.
19. 2+ transient of failing human ventricular myocytes. Circ. Res. (1999) 84:435-444.
20. LITWIN SE, LI J, BRIDGE JH: Na-Ca exchange and the trigger for sarcoplasmic reticulum Ca release: studies in adult rabbit ventricular myocytes. Biophys. J. (1998) 75:359-371.
21. BEUCKELMANN DJ, NABAUER M, ERDMANN E: Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure [see comments]. Circulation (1992) 85:1046-1055.
22. O'ROURKE B, KASS DA, TOMASELLI GF et al.: Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ. Res. (1999) 84:562-570.
23. 2+ exchange activity in canine pacing-induced heart failure. Circ. Res. (2000) 87:690-698.
24. 2+ exchanger in end-stage human heart failure. Circ. Res. (1994) 75:443-453.
25. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ. Res. (1999) 85:1009-1019.
26. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation (1999) 99:641-648.
27. 2+-ATPase in ventricular myocytes from transgenic mice. Cardiovasc. Res. (2001) 49:38-47.
28. EISNER DA, TRAFFORD AW, DIAZ ME et al.: The control of Ca release from the cardiac sarcoplasmic reticulum: regulation versus autoregulation. Cardiovasc. Res. (1998) 38:589-604.
29. HOBAI I, O'ROURKE B: Restoration of Ca handling by Na/Ca exchange blockade in canine pacing-induced heart failure. Circulation (2002) 106:II-177.
30. BROWN HF, KIMURA J, NOBLE D et al.: The slow inward current, isi, in the rabbit sino-atrial node investigated by voltage clamp and computer simulation. Proc. R. Soc. Lond. B. Biol. Sci. (1984) 222:305-328.
31. 2+ influx during the cardiac action potential in guinea pig ventricular myocytes. Circ. Res. (1996) 79:194-200.
32. JANVIER NC, BOYETT MR: The role of Na-Ca exchange current in the cardiac action potential. Cardiovasc. Res. (1996) 32:69-84.
33. 2+ exchange current in the ferret ventricular action potential. J. Physiol. (1997) 498(Pt. 3):611-625.
34. ARMOUNDAS AA, HOBAI IA, TOMASELLI GF et al.: Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ. Res. (2003) 93:46-53.
35. 2+] during the cardiac action potential. Circ. Res. (2002) 90:182-189.
36. POGWIZD SM, SCHLOTTHAUER K, LI L et al.: Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ. Res. (2001) 88:1159-1167.
37. 2+ exchanger in end-stage failing human myocardium. Eur. Heart J. (2002) 23:1118-1124.
38. MARKS AR: Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J. Mol. Cell. Cardiol. (2001) 33:615-624.
39. + exchanger during ischemia and preconditioning in the isolated rat heart. Circ. Res. (1999) 85:723-730.
40. i] in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ. Res. (1990) 66:1255-1267.
41. DOERING AE, LEDERER WJ: The mechanism by which cytoplasmic protons inhibit the sodium-calcium exchanger in guinea-pig heart cells. J. Physiol (1993) 466:481-499.
42. 2+ exchanger by extracellular protons in guinea-pig ventricular myocytes. J. Physiol. (2000) 523(Pt. 2):353-366.
43. MATTHEWS HR, MURPHY RL, FAIN GL et al.: Photoreceptor light adaptation is mediated by cytoplasmic calcium concentration. Nature (1988) 334:67-69.
44. 2+ exchange in cells expressing NCX1. J. Biol. Chem. (1996) 271:22391-22397.
45. 2+ exchange current in guinea-pig cardiac ventricular cells. Br. J. Pharmacol. (1996) 119:555-563.
46. 2+ exchanger. Mol. Pharmacol. (2001) 59:524-531.
47. TANAKA H, NISHIMARU K, AIKAWA T et al.: Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents. Br. J. Pharmacol. (2002) 135:1096-1100.
48. 2+ exchange inhibitor, on myocardial ischemia/reperusion injury]. Nippon Yakurigaku Zasshi (1998) 111:105-115.
49. 2+ exchanger inhibitor, KB-R7943, caused negative inotropic responses and negative followed by positive chronotropic responses in isolated, blood-perfused dog heart preparations. Jpn J. Pharmacol. (2000) 82:155-163.
50. 2+ exchange under normal and sodium-loaded conditions in mammalian ventricles. Mol. Cell. Biochem. (2003) 242:11-17.
51. 2+ exchange inhibitor, KB-R7943 on ouabain-induced arrhythmias in guinea-pigs. Br. J. Pharmacol. (1999) 127:1846-1850.
52. 2+ exchange inhibitor, does not suppress ischemia/reperfusion arrhythmias nor digitalis arrhythmias in dogs. Jpn J. Pharmacol. (2002) 90:229-235.
53. 2+ overload in rat ventricular myocytes. Circulation (2000) 101:1441-1446.
54. 2+ exchanger inhibitors SEA0400 and KB-R7943. Am. J. Physiol. Heart Circ Physiol (2003) 284:H903-H910.
55. 2+ overload in ischemic-reperfused rat hearts. Circ. J. (2002) 66:390-396.
56. 2+ exchanger. Am. J. Physiol. (1999) 276:H1868-H1876.
57. 2 in quiescent isolated rat cardiomyocytes. Basic Res. Cardiol. (2001) 96:623-629.
58. 2+ exchange. Circ. Res. (2002) 90:988-995.
59. 2+ exchanger as responsible for myocardial stunning]. Medicina (2001) 61:167-173.
60. 2+ exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc. Res. (2002) 55:739-748.
61. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J. Pharmacol. Exp. Ther. (2001) 298:249-256.
62. 2+ exchange inhibitors. Circ. Res. (2002) 91:90-92.
63. 2+ exchanger, on myocardial ischemia-reperfusion injuries. Eur. J. Pharmacol. (2003) 458:155-162.
64. 2+ exchange in membrane vesicle and papillary muscle preparations from guinea pig heart by analogs of amiloride. Proc. Natl. Acad. Sci. USA (1984) 81:3238-3242.
65. + exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs (2001) 61:375-389.
66. KLEYMAN TR, CRAGOE EJ Jr: Amiloride and its analogs as tools in the study of ion transport. J. Membr. Biol. (1988) 105:1-21.
67. MURATA Y, HARADA K, NAKAJIMA F et al.: Non-selective effects of amiloride and its analogues on ion transport systems and their cytotoxicities in cardiac myocytes. Jpn. J. Pharmacol. (1995) 68:279-285.
68. KIM D, SMITH TW: Inhibition of multiple trans-sarcolemmal cation flux pathways by dichlorobenzamil in cultured chick heart cells. Mol. Pharmacol. (1986) 30:164-170.
69. 45Ca transport in isolated adult cardiac cells. Can. J. Physiol. Pharmacol. (1984) 62:575-580.
70. KACZOROWSKI GJ, SLAUGHTER RS, KING VF et al.: Inhibitors of sodium-calcium exchange: identification and development of probes of transport activity. Biochim. Biophys. Acta (1989) 988:287-302.
71. 2+ fluxes in brain synaptic membrane vesicles. Biochem. Pharmacol. (1983) 32:963-969.
72. HAWORTH RA, GOKNUR AB, BERKOFF HA: Inhibition of Na-Ca exchange by general anesthetics. Circ. Res. (1989) 65:1021-1028.
73. ERDREICH A, SPANIER R, RAHAMIMOFF H: The inhibition of Na-dependent Ca uptake by verapamil in synaptic plasma membrane vesicles. Eur. J. Pharmacol. (1983) 90:193-202.
74. 2+ exchange in heart sarcolemmal vesicles. Proc. Natl. Acad. Sci. USA (1980) 77:6354-6358.
75. 2+ exchange activity by ascorbate in rat brain membrane vesicles. Brain Res. (1990) 532:13-18.
76. CHIN TK, SPITZER KW, PHILIPSON KD et al.: The effect of exchanger inhibitory peptide (XIP) on sodium-calcium exchange current in guinea pig ventricular cells. Circ. Res. (1993) 72:497-503.
77. 2+ of Na/Ca exchange and L-type Ca channel in rabbit ventricular myocytes. Am. J. Physiol. (1997) 272: H2164-H2172.
78. 2+ exchange in rat and human brain plasma membrane vesicles. J. Neurochem. (1994) 63:2136-2143.
79. 2+ transporters cross-react. J. Biol. Chem. (1993) 268:17120-17125.
80. HALE CC, BLILER S, QUINN TP et al.: Localization of an exchange inhibitory peptide (XIP) binding site on the cardiac sodium-calcium exchanger. Biochem. Biophys. Res. Commun. (1997) 236:113-117.
81. 2+ exchanger by the endogenous XIP region. J. Gen. Physiol. (1997) 109:273-286.
82. 2+ exchange in inside-out patches excised from guinea-pig ventricular myocytes. J. Physiol. (2000) 523 Pt 2:339-351.
83. 2+ exchange in rabbit ventricular myocytes. Pflugers Arch. (1998) 436:976-983.
84. 2+ exchange in cardiac sarcolemma vesicles. Life Sci. (1992) 51:275-283.
85. DIPOLO R, BEAUGE L: Cardiac sarcolemmal Na/Ca-inhibiting peptides XIP and FMRF-amide also inhibit Na/Ca exchange in squid axons. Am. J. Physiol. (1994) 267:C307-C311.
86. 2+ exchange in cardiac sarcolemma vesicles. J. Biol. Chem. (1993) 268:200-205.
87. 2+ exchanger. J. Biol. Chem. (1995) 270:16182-16188.
88. HOBAI IA, KHANANSHVILI D, LEVI AJ: The peptide 'FRCRCFa', dialysed intracellularly, inhibits the Na/Ca exchange in rabbit ventricular myocytes with high affinity. Pflugers Arch. (1997) 433:455-463.
89. MESZAROS J, KHANANSHVILI D, HART G: Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats. Am. J. Physiol. Heart Circ. Physiol. (2001) 281: H903-H914.
90. CONVERY MK, LEVI AJ, KHANANSHVILI D et al.: Actions of myristyl-FRCRCFa, a cell-permeant blocker of the cardiac sarcolemmal Na-Ca exchanger, tested in rabbit ventricular myocytes. Pflugers Arch. (1998) 436:581-590.
91. NIGGLI E, SCHWALLER B, LIPP P: Antisense oligodeoxynucleotides directed against the Na-Ca exchanger mRNA. Promising tools for studies on the cellular and molecular level. Ann. NY Acad. Sci. (1996) 779:93-102.
92. i transients in adult fat myocytes. Am. J. Physiol. Heart Circ. Physiol. (2002) 283:H1616-H1626.
93. MITCHESON JS, HANCOX JC, LEVI AJ: Action potentials, ion channel currents and transverse tubule density in adult rabbit ventricular myocytes maintained for 6 days in cell culture. Pflugers Arch. (1996) 431:814-827.